Enhancing the adaptive immune system to fight cancer, including B lymphocytes, CD4+ helper T lymphocytes, and CD8+ cytotoxic T lymphocytes, is a promising therapeutic strategy for cancer. The gene discussed is CD8A; the disease is cancer.